Dabur Pharma UK subsidiary to be responsible for operations in USA

Dabur Pharma Ltd has announced that Dabur Oncology Plc., the Wholly Owned Subsidiary of the Company in UK, has incorporated a Subsidiary Company in the U.S.A which will now be directly responsible for Sales, Marketing and Distribution of Oncology Products in the U.S.A.

The stock was trading at Rs.61.85, down by Rs.1.60 or 2.52%. The stock hit an intraday high of Rs.63.95 and low of Rs.61.50. The total traded quantity was 9853 compared to 2 week average of 27204.

Source : Equity Bulls

Keywords